Cardinal Health (CAH) stock declines 0.8% after missing Q4 revenue targets, but strong full-year EPS guidance of $12.40-$12.60 beats estimates. The post Cardinal Health (CAH) Stock: Robust FY Forecast Overshadows Q4 Revenue Shortfall appeared first on Blockonomi.